Doç. Dr. NECİBE BAŞARAN MUTLU AĞARDAN

Yayın Ağı

Makaleler 28

1. In vitro/in vivo evaluation of 3D bioprinted silk fibroin hydrogels for IBD: A dual mesalazine and TNF-α siRNA approach

YILDIZ A., MUTLU AĞARDAN N. B., ÖZGENÇ ÇINAR Ö., CEYLAN A., UYAR R., YURDAKÖK DİKMEN B., et al.

European Journal of Pharmaceutical Sciences , cilt.213, 2025 (SCI-Expanded)

2. In vitro assessment of hyaluronic acid and chitosan based nanoparticles as pH sensitive drug carriers for rheumatoid arthritis

Durmaz N., MUTLU AĞARDAN N. B., Parlak H.

Journal of Drug Delivery Science and Technology , cilt.111, 2025 (SCI-Expanded)

3. Evaluation the potential of γ-cyclodextrin metal-organic frameworks in enhancing tamoxifen citrate solubility and permeability focusing on particle size

MUTLU AĞARDAN N. B., EDİSAN Ş., GÜLSÜN İNAL T.

Journal of Drug Delivery Science and Technology , cilt.104, 2025 (SCI-Expanded)

4. AN OVERVIEW OF 3D PRINTING TECHNOLOGIES FOCUSING MULTIDRUG-LOADED 3D PRINTED DOSAGE FORMS

Yılmaz A., Mutlu Ağardan N. B., Takka S.

ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.49, sa.1, ss.228-240, 2025 (Scopus)

5. Development of immediate release tablet formulations of lornoxicam with hot melt extrusion-based three-dimensional printing technology

Yilmaz A., Mutlu-Agardan N. B., TAKKA S.

Drug Development and Industrial Pharmacy , cilt.51, sa.1, ss.64-76, 2025 (SCI-Expanded)

6. Prevention of secondary caries using fluoride-loaded chitosan nanoparticle-modified glass-ionomer cement

ALTINIŞIK H., Erten Can H., MUTLU AĞARDAN N. B., BERKKAN A., Güney M.

Clinical Oral Investigations , cilt.28, sa.9, 2024 (SCI-Expanded)

7. Preparation and evaluation the effects of retinoic acid loaded proliposomal nanofibers on microbial biofilm inhibition

Tort S., Öztürk Z. C., Kaynak Onurdağ F., Mutlu-Agardan N. B.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.29, sa.9, ss.955-965, 2024 (SCI-Expanded)

8. Evaluation of the effect of process parameters on the protein content of silk fibroin

Yıldız A., MUTLU AĞARDAN N. B., ACARTÜRK F.

Polymer Bulletin , cilt.80, sa.12, ss.13181-13198, 2023 (SCI-Expanded)

9. Cholesterol included self-assembled electrospun proliposomes as a feasible approach for drug delivery

Mutlu-Ağardan N. B., TORT S.

Journal of Drug Delivery Science and Technology , cilt.86, 2023 (SCI-Expanded)

10. AN OVERWIEW OF TARGETED DRUG DELIVERY SYSTEMS FOR RHEUMATOID ARTHRITIS TREATMENT ROMATOID ARTRIT TEDAVISINDE HEDEFLENDIRILMIŞ ILAÇ TAŞIYICI SISTEMLERE GENEL BAKIS

Durmaz N., Aǧardan N. B.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.48, sa.1, ss.1-15, 2023 (Scopus)

11. A New Insight to Silver Sulfadiazine Antibacterial Dressings: Nanoparticle-Loaded Nanofibers for Controlled Drug Delivery

Mutlu-Ağardan N. B., Tort S., Aydoğduoğlu Ş., Kıymacı M. E.

AAPS PHARMSCITECH , cilt.24, sa.1, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Nanopartiküler İlaç Taşıyıcı Sistemler ile Oral İnsülin Tedavisinde Son Gelişmeler: Sistematik Derleme

Mutlu Ağardan N. B.

Literatür Eczacılık Bilimleri Dergisi , cilt.11, sa.1, ss.104-118, 2022 (Hakemli Dergi)

13. Development of cyclosporine A nanosuspension: cytotoxicity and permeability on Caco-2 cell lines

Pinar S. G., PEZİK E., Agardan B. M., Celebi N.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.27, sa.1, ss.52-62, 2022 (SCI-Expanded)

14. Development of effective AmB/AmB–αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment

Mutlu-Agardan N. B., Yilmaz S., KAYNAK ONURDAĞ F., Celebi N.

Journal of Liposome Research , cilt.31, sa.2, ss.177-188, 2021 (SCI-Expanded)

15. In vitro and in vivo evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin delivery.

Mutlu-Agardan N. B., Han S.

Pharmaceutical development and technology , cilt.26, ss.157-166, 2021 (SCI-Expanded)

16. ALT ÜNİTE BAZLI AŞILARIN PULMONER UYGULAMASINA GENEL BAKIŞ

Ongun M., Mutlu Ağardan N. B., Acartürk F.

ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.45, sa.1, ss.109-130, 2021 (Scopus) Sürdürülebilir Kalkınma

17. In vitroandin vivoevaluation of microneedles coated with electrosprayed micro/nanoparticles for medical skin treatments

TORT S., MUTLU AĞARDAN N. B., Han D., Steckl A. J.

JOURNAL OF MICROENCAPSULATION , cilt.37, sa.7, ss.517-527, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer

Agardan N. B., Degim Z., Yilmaz S., Altintas L., Topal T.

Journal of Drug Delivery Science and Technology , cilt.57, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Studies on the formulation optimization and controlled ionic gelation of chitosan nanoparticles using TPP-HP-beta-CD inclusion complex

Agardan M.

ISTANBUL JOURNAL OF PHARMACY , cilt.50, sa.1, ss.54-59, 2020 (ESCI)

20. Cytotoxicity of Novel Redox Sensitive PEG2000-S-S-PTX Micelles against Drug-Resistant Ovarian and Breast Cancer Cells

Mutlu-Agardan N. B., Sarisozen C., Torchilin V. P.

Pharmaceutical Research , cilt.37, sa.3, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

21. Redox-triggered intracellular siRNA delivery

MUTLU AĞARDAN N. B., Sarisozen C., Torchilin V. P.

CHEMICAL COMMUNICATIONS , cilt.54, sa.49, ss.6368-6371, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Development of Liposome Formulations ofTamoxifen and Assessment of Caco-2 CellTransportation Properties

MUTLU AĞARDAN N. B., DEĞİM Z., Yılmaz Ş.

FABAD J. Pharm. Sci , cilt.43, sa.1, ss.1-6, 2018 (Scopus)

23. The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy

MUTLU AĞARDAN N. B., Degim Z., Yilmaz S., Altintas L., Topal T.

AAPS PHARMSCITECH , cilt.17, sa.4, ss.968-977, 2016 (SCI-Expanded)

24. Antitumoral and MMP-2 inhibition activity of raloxifene or tamoxifen loaded nanoparticles containing dimethyl-beta-cyclodextrin

Agardan N. B., Degim Z., Yilmaz S.

JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY , cilt.80, ss.31-36, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

25. New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations

MUTLU AĞARDAN N. B., Degim Z., Yilmaz S., EŞSİZ D., NACAR A.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.37, sa.7, ss.775-789, 2011 (SCI-Expanded)

26. Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2)

Degim Z., Mutlu N. B., Yilmaz S., Essiz D., Nacar A.

Pharmazie , cilt.65, sa.1, ss.32-40, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

27. DEVELOPMENT OF LIPOSOME FORMULATION OF RIVASTIGMINE AND INVESTIGATION OF TRANSPORT PROPERTIES THROUGH MDCK AND CACO-2 CELL LINES

Degim Z., MUTLU AĞARDAN N. B., Yilmaz S., EŞSİZ D.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.88-89, 2009 (SCI-Expanded)

28. Bioavailability file: Rivastigmine tartrate

Mutlu N. B., Deǧim Z.

Fabad Journal of Pharmaceutical Sciences , cilt.30, sa.3, ss.150-157, 2005 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 39

1. Optimization of γ-CD-MOFs Prepared Using Different Particle Size Modulators: TEA,CTAB and PEG20000

Mutlu Ağardan N. B., Edisan Ş.

European Federation for Pharmaceutical Sciences, Vienna, Avusturya, 19 - 21 Şubat 2025, (Özet Bildiri)

2. DEVELOPMENT AND CHARACTERIZATION OF TAMOXIFEN CITRATE LOADED Ɣ-CYCLODEXTRIN METAL ORGANIC FRAMEWORKS

Mutlu Ağardan N. B., Edisan Ş.

14th International Symposium on Pharmaceutical Science, Ankara, Türkiye, 25 - 28 Haziran 2024, (Özet Bildiri)

3. Tamoxifen Citrate-Loaded γ-Cyclodextrin Metal Organic Frameworks: Studies on permeability through Caco-2 cell monolayers

MUTLU AĞARDAN N. B., EDİSAN Ş., GÜLSÜN İNAL T.

21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, (Özet Bildiri)

4. Evaluation of the cytotoxicity and in vitro TNF-α silencing efficiency of the mesalazine and TNF-α siRNA loaded 3D bioprinted hydrogels

Yıldız A., Mutlu Ağardan N. B., Uyar R., Yurdakök Dikmen B., Acartürk F.

21st International Pharmaceutical Technology Symposium, Ankara, Türkiye, 9 - 11 Eylül 2024, ss.70, (Özet Bildiri)

5. Development and in vitro evaluation of mesalazine and chitosan/TNF-α siRNA polyplex loaded silk fibroin-based hydrogels by 3D bioprinting

Yıldız A., Mutlu Ağardan N. B., Acartürk F.

14th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 25 - 28 Haziran 2024, ss.85, (Özet Bildiri)

6. Effect of Plasticizers on Soluplus® filaments Produced with Hot Melt Extrusion Technique

Yılmaz A., Mutlu Ağardan N. B., Takka S.

5th International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2022, Ankara, Türkiye, 23 - 25 Kasım 2022, ss.317, (Özet Bildiri)

7. Preparation and In Vitro Release Studies of Mesalazine Loaded Silk Fibroin Based Nanoparticles

YILDIZ A., MUTLU AĞARDAN N. B., ACARTÜRK F.

16th Nanoscience & Nanotechnology Conference (NANOTR-16), Ankara, Türkiye, 5 - 08 Eylül 2022, (Özet Bildiri)

8. Preparation and in vitro release studies of mesalazine loaded silk fibroin-based nanoparticles

Yıldız A., Mutlu Ağardan N. B., Acartürk F.

16th NANOSCIENCE & NANOTECHNOLOGY CONFERENCE, Ankara, Türkiye, 5 - 08 Eylül 2022, ss.341, (Özet Bildiri)

9. Development of Mesalazine Loaded Hydrogel Formulations by 3D Printing Technology

YILDIZ A., MUTLU AĞARDAN N. B., ACARTÜRK F.

20th International Pharmaceutical Technology Symposium, Ankara, Türkiye, 21 - 23 Şubat 2022, (Tam Metin Bildiri)

10. Development of Mesalazine Loaded Hydrogel Formulations by 3D Printing Technology

Yıldız A., Mutlu Ağardan N. B., Acartürk F.

20th International Pharmaceutical Technology Symposium, Ankara, Türkiye, 21 - 23 Şubat 2022, ss.1, (Tam Metin Bildiri)

11. Optimization and validation of silk fibroin production process

Yıldız A., MUTLU AĞARDAN N. B., ACARTÜRK F.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 08 Eylül 2021, ss.144, (Özet Bildiri)

12. The effects of a new cyclosporine A nanosuspension on nephrotoxicity after oral administration: HK-2 cell culture and in vivo histopathological evaluation

GÜLBAĞ PINAR S., MUTLU AĞARDAN N. B., IŞIK GÖNÜL İ., ÇELEBİ F. N.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 08 Eylül 2021, (Özet Bildiri)

13. Preparation of chitosan tripolyphosphate and chitosan sulfobutyl-ether-β-cyclodextrin nanoparticles for oral insulin delivery

Turan T., MUTLU AĞARDAN N. B.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 08 Eylül 2021, ss.109, (Özet Bildiri)

14. Optimization and Validation of Silk Fibroin Production Process

YILDIZ A., MUTLU AĞARDAN N. B., ACARTÜRK F.

3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, (Özet Bildiri)

15. Studies on formulation optimisation of hyaluronic acid coated chitosan nanoparticles loaded with hydrocortisone acetate

Durmaz N., MUTLU AĞARDAN N. B.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 08 Eylül 2021, ss.149, (Özet Bildiri)

16. Romatoid Artrit Tedavisinde Kullanılmak Üzere Hedeflendirilmiş Nanopartiküllerin Deney Tasarımı ile Geliştirilmesi Üzerine Çalışmalar

Durmaz N., MUTLU AĞARDAN N. B.

7th International Hippocrates Congress on Medical and Health Sciences, Ankara, Türkiye, 03 Eylül 2021, (Özet Bildiri)

17. Studies on modifications of established silk fibroin production methods to enhance protein content

YILDIZ A., MUTLU AĞARDAN N. B., ACARTÜRK F.

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Viyana, Avusturya, 11 - 15 Mayıs 2021, (Tam Metin Bildiri)

18. Studies on modifications of established silk fibroin production methods to enhance protein content

Yıldız A., MUTLU AĞARDAN N. B., ACARTÜRK F.

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Türkiye, 11 Mayıs 2021, (Tam Metin Bildiri)

19. Evaluation of Dissolution Properties of Cyclosporine a Nanosuspensions Prepared with Two Different Top Down Technologies

GÜLBAĞ S., MUTLU AĞARDAN N. B., ÇELEBİ F. N.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

20. Development of Amphotericin B loaded chitosan sulfobutylether-β-cyclodextrin nanoparticles with sodium deoxycholate

MUTLU AĞARDAN N. B.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Türkiye, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

21. The Effect of Process Parameters of the Cyclosporine A Nanosuspension Produced by Wet Milling Stabilized with Hydroxypropyl methylcellulose

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., ÇELEBİ F. N.

Controlled Release Society (CRS) Annual Meeting Exposition, Valencia, İspanya, 21 - 24 Temmuz 2019, (Tam Metin Bildiri)

22. AmB / AmB-αCD çifte yüklü lipozomların antifungal etkinlik ve sitotoksisite çalışmaları

MUTLU AĞARDAN N. B., KAYNAK ONURDAĞ F., yılmaz ş., çelebi n.

2. Ulusal Marmara Eczacılık Kongresi (UMEK-2), İstanbul, Türkiye, 14 - 16 Kasım 2018, (Tam Metin Bildiri)

23. Preformulation studies of cyclosporine A nanosuspension stabilized by hydroxypropyl methylcellulose and soluplus

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., Çelebi N.

12th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

24. Studies on formulation development of amphotericin B-double loaded liposomes using design of experiment (DoE)

MUTLU AĞARDAN N. B., Çelebi N.

EUFEPS Annual Meeting 2018, Atina, Yunanistan, 24 - 26 Mayıs 2018, (Özet Bildiri)

25. Top down production of cyclosporine A nanosuspensions: Formulation design and characterization for oral delivery

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., ÇELEBİ N.

EUFEPS Annual Meeting 2018, Atina, Yunanistan, 24 - 26 Mayıs 2018, (Özet Bildiri)

26. Preparation and characterization of cyclosporine A nanosuspensions for oral administration II: The effect of Poloxamer types on physical stability of formulations

GÜLBAĞ S., KARAKÜÇÜK A. E., MUTLU AĞARDAN N. B., Çelebi F. N.

11th WORLD MEETING on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Nikaragua, 19 - 21 Mart 2018, (Özet Bildiri)

27. Redox potential sensitive smart nanopreparations for drug and siRNA delivery in cancer

MUTLU AĞARDAN N. B.

16th International Conference and Exhibition on Pharmaceutics Novel Drug Delivery Systems, Berlin, Almanya, 19 - 21 Mart 2018, cilt.7, ss.46, (Özet Bildiri) Sürdürülebilir Kalkınma

28. Development of Amphotericin B-double loaded liposomes using design of experiment (DoE)

MUTLU AĞARDAN N. B., Çelebi N.

16th International Conference and Exhibition on Pharmaceutics Novel Drug Delivery Systems, Berlin, Almanya, 19 - 21 Mart 2018, cilt.47, ss.88, (Özet Bildiri)